Inoue T, Inoue T, Yamazaki H, Koizumi M, Kagawa K, Yoshida K, Shiomi H, Imai A, Shimizutani K, Tanaka E, Nose T, Teshima T, Furukawa S, Fuchihata H
Department of Radiation Oncology, Biomedical Research Center, Osaka University Medical School, Suita, Japan.
Int J Radiat Oncol Biol Phys. 1998 Apr 1;41(1):53-8. doi: 10.1016/s0360-3016(98)00041-8.
Patients with cancer of the floor of mouth are treated with radiation because of functional and cosmetic reasons. We evaluate the treatment results of high dose rate (HDR) and low dose rate (LDR) interstitial radiation for cancer of the floor of mouth.
From January 1980 through March 1996, 41 patients with cancer of the floor of mouth were treated with LDR interstitial radiation using 198Au grains, and from April 1992 through March 1996 16 patients with HDR interstitial radiation. There were 26 T1 tumors, 30 T2 tumors, and 1 T3 tumor. For 21 patients treated with interstitial radiation alone, a total radiation dose of interstitial therapy was 60 Gy/10 fractions/6-7 days in HDR and 85 Gy within 1 week in LDR. For 36 patients treated with a combination therapy, a total dose of 30 to 40 Gy of external radiation and a total dose of 48 Gy/8 fractions/5-6 days in HDR or 65 Gy within 1 week in LDR were delivered.
Two- and 5-year local control rates of patients treated with HDR interstitial radiation were 94% and 94%, and those with LDR were 75% and 69%, respectively. Local control rate of patients treated with HDR brachytherapy was slightly higher than that with 198Au grains (p = 0.113). For late complication, bone exposure or ulcer occurred in 6 of 16 (38%) patients treated with HDR and 13 of 41 (32%) patients treated with LDR.
HDR fractionated interstitial brachytherapy can be an alternative to LDR brachytherapy for cancer of the floor of mouth and eliminate radiation exposure for the medical staff.
由于功能和美观原因,口底癌患者采用放射治疗。我们评估高剂量率(HDR)和低剂量率(LDR)组织间放射治疗口底癌的治疗效果。
从1980年1月至1996年3月,41例口底癌患者采用198Au粒子进行LDR组织间放射治疗,从1992年4月至1996年3月,16例患者采用HDR组织间放射治疗。有26例T1期肿瘤、30例T2期肿瘤和1例T3期肿瘤。对于仅接受组织间放射治疗的21例患者,组织间治疗的总放射剂量在HDR为每6 - 7天60 Gy/10次分割,在LDR为1周内85 Gy。对于接受联合治疗的36例患者,外照射总剂量为30至40 Gy,HDR组织间放射治疗总剂量为48 Gy/8次分割/5 - 6天,或LDR组织间放射治疗总剂量为1周内65 Gy。
接受HDR组织间放射治疗患者的2年和5年局部控制率分别为94%和94%,接受LDR组织间放射治疗患者的局部控制率分别为75%和69%。接受HDR近距离治疗患者的局部控制率略高于接受198Au粒子治疗的患者(p = 0.113)。对于晚期并发症,接受HDR治疗的16例患者中有6例(38%)发生骨暴露或溃疡,接受LDR治疗的41例患者中有13例(32%)发生。
HDR分次组织间近距离治疗可作为口底癌LDR近距离治疗的替代方法,并消除医务人员的辐射暴露。